Momenxsin (Pseudoephedrine Hydrochloride, Ibuprofen)

Pseudoephedrine Hydrochloride/Ibuprofen, the active ingredient in Momenxsin, is a sympathomimetic and non‑steroidal anti‑inflammatory drug presented as an oral tablet for oral use. It relieves nasal congestion, pain, fever and other symptoms associated with colds or flu in adults and adolescents. GNH USA supplies Momenxsin as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Momenxsin combines a decongestant and an NSAID to address several common cold‑and‑flu related conditions.

Nasal congestion: reduces swelling of nasal mucosa and eases breathing Headache: alleviates pain through anti‑inflammatory action Fever: lowers elevated body temperature Pain associated with cold or flu: provides analgesic relief

Momenxsin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Insomnia: difficulty falling or staying asleep - Nervousness: feeling jittery or anxious - Dry mouth: reduced salivation - Nausea: upset stomach or urge to vomit

Serious or Rare Side Effects: - High blood pressure: significant rise in systolic or diastolic pressure - Gastrointestinal bleeding: blood in stool or vomit - Severe allergic reaction: rash, swelling, or breathing difficulty - Renal impairment: reduced urine output or swelling of extremities

Before using Momenxsin, consider the following safety measures.

Assess cardiovascular status: monitor blood pressure, especially in hypertensive patients Evaluate renal function: avoid in severe kidney disease without medical supervision Review medication history: contraindicated with MAO inhibitors and other sympathomimetics Use caution in pregnancy: consult a healthcare professional before use Store at ambient temperature: keep in the original pack, protect from moisture.

Momenxsin can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis - Other sympathomimetics: additive cardiovascular stimulation - Anticoagulants/antiplatelet agents: increased bleeding risk

Moderate Interactions (Monitor Closely):\n- Antihypertensives: possible reduction in blood‑pressure‑lowering effect - Lithium: potential increase in lithium serum levels